Antibody-Drug Conjugates in Bladder Cancer

Urothelial carcinoma (UC) is characterized by expression of a plethora of cell surface antigens, thus offering opportunities for specific therapeutic targeting with use of antibody-drug conjugates (ADCs). ADCs are structured from two major constituents, a monoclonal antibody (mAb) against a specific...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Bladder Cancer
Asıl Yazarlar: Vlachostergios, Panagiotis J., Jakubowski, Christopher D., Niaz, Muhammad J., Lee, Aileen, Thomas, Charlene, Hackett, Amy L., Patel, Priyanka, Rashid, Naureen, Tagawa, Scott T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: IOS Press 2018
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6087439/
https://ncbi.nlm.nih.gov/pubmed/30112436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-180169
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller